$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What are the side effects of Osimertinib (Tagressa)? How to deal with side effects?
2026-02-01 22:25:32
Check Details
Patient instructions for the targeted drug osimertinib mesylate (Tagrisso) for the treatment of lung cancer
2026-02-01 22:25:32
Check Details
Usage, dosage and best time of taking osimertinib mesylate (Tagressa)
2026-02-01 22:25:32
Check Details
How long does it take for Osimertinib (Tagressa) to become resistant to drug resistance?
2026-02-01 22:25:32
Check Details
Is Osimertinib (Tagressa) a domestic drug or an imported drug?
2026-02-01 22:25:32
Check Details
What are the indications for Osimertinib (Tagressa)?
2026-02-01 22:25:32
Check Details
How much does the third-generation targeted drug Osimertinib (Tagrisso) cost?
2026-02-01 22:25:32
Check Details
How long does it take for the side effects of Osimertinib (Tagressa) to disappear?
2026-02-01 22:25:32
Check Details
Is it better to take Osimertinib (Tagressa) before or after meals?
2026-02-01 22:25:32
Check Details
Efficacy and adverse reactions of osimertinib (Tagrisso)
2026-02-01 22:25:32
Check Details
What is the difference between osimertinib (Tagressa) and fumetinib?
2026-02-01 22:25:32
Check Details
How long does it take for resistance to Osimertinib (Tagressa) to develop? How to deal with drug resistance?
2026-02-01 22:25:32
Check Details
1
2
...
691
692
693
694
695
696
697
...
10237
10238
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Vosoritide Side Effects and Pre-Injection Food/Fluid: Injection-Site Reactions, Transient Hypotension
2
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
3
Pretomanid Mechanism and BPaL Use in Drug-Resistant TB
4
Pacritinib Drug Contraindications and Precautions
5
Pomalidomide Side Effects, Risk Monitoring, and Precautions
6
Dasatinib for Ph+ Chronic Myeloid Leukemia: Dosage, Administration, and Long-Term Care
7
Obeticholic Acid 5 mg for PBC: Dosage, Risks, and Current Status
8
Acalabrutinib Monotherapy for CLL: What It Can and Cannot Do
9
Bepirovirsen for Chronic HBV Functional Cure: FDA Criteria and B-Well Data
10
After Ibrutinib Resistance: CLL/SLL and MCL Next Steps, Progression vs Intolerance
11
Tucatinib HER2 TKI: With Trastuzumab + Capecitabine, Diarrhea and Hepatotoxicity Monitoring
12
Quizartinib for FLT3-ITD AML: Induction-Consolidation-Maintenance and QT Monitoring